GB1052224A - - Google Patents

Info

Publication number
GB1052224A
GB1052224A GB1052224DA GB1052224A GB 1052224 A GB1052224 A GB 1052224A GB 1052224D A GB1052224D A GB 1052224DA GB 1052224 A GB1052224 A GB 1052224A
Authority
GB
United Kingdom
Prior art keywords
hydrogen
halogen
lower alkyl
ethinyl
acyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Publication of GB1052224A publication Critical patent/GB1052224A/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,052,224. Medicines comprising steroids. SCHERICO Ltd. Dec. 20, 1963 [Jan. 16, 1963 (2); March 7, 1963], No. 50366/63. Heading A5B. [Also in Division C2]. Therapeutic compositions having steroid hormone activity comprise a compound of the formula:- wherein A is (H,H), (H, α-Lower alkyl), (H, #-lower alkyl), lower alkylene, (H, α-hydroxy) or (H, α-acyloxy); B is hydrogen, lower alkyl or halogen; R is hydrogen, lower alkyl or acyl; of- X and Y, X is hydrogen or halogen and Y is a (H,H), Keto, (H, α-OR<SP>1</SP>), (H, #- OR<SP>1</SP>) or (H, #-halogen) R<SP>1</SP> being hydrogen or acyl, whereby X is hydrogen when Y is (H, H) or (H, α-OH), and X is halogen when Y is (H, #-halogen), or X and Y together represent an epoxy grouping or a double bond; and Z is one of the groupings D being hydrogen, lower alkyl, ethinyl, halogeno-ethinyl or alkyl-ethinyl, Q being hydrogen, hydroxy, acyloxy or halogen, R<SP>11</SP> being hydrogen or acyl and V being hydrogen, hydroxy or acyloxy, in admixture with a pharmaceutical carrier. Certain of the compounds have progestational and anti-fertility properties while others have anabolic and anti-inflammatory properties and are employed orally. Compounds having anti-inflammatory activity may, for example be administered in tablets or capsules, syrups, or emulsions intramuscularly in suspension, topically as a cream to which may be added neomycin sulphate, or in opthalmic suspensions or nasal sprays.
GB1052224D Active GB1052224A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1052224T

Publications (1)

Publication Number Publication Date
GB1052224A true GB1052224A (en)

Family

ID=10870669

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1052224D Active GB1052224A (en)

Country Status (2)

Country Link
BE (1) BE642576A (en)
GB (1) GB1052224A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095749A2 (en) * 1982-05-28 1983-12-07 E.R. Squibb &amp; Sons, Inc. 17-Spiroandrostenes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095749A2 (en) * 1982-05-28 1983-12-07 E.R. Squibb &amp; Sons, Inc. 17-Spiroandrostenes
EP0095749A3 (en) * 1982-05-28 1985-01-09 E.R. Squibb & Sons, Inc. 17-spiroandrostenes

Also Published As

Publication number Publication date
BE642576A (en)

Similar Documents

Publication Publication Date Title
EP0413269B1 (en) 4-substituted 17-beta-(cyclopropyloxy)androst-5-EN-3-beta-OL and related compounds useful as C17-20 lyase inhibitors
US4081537A (en) Δ15 -Steroids and pharmaceutical compositions thereof
US2793218A (en) 9alpha-halo-11-keto-17-alkyltestosterones
GB1052224A (en)
DE3872938T2 (en) 17-BETA- (CYCLOPROPYLOXY) ANDROST-5-EN-3-BETA-OL DERIVATIVES AND RELATED COMPOUNDS AS C17-20 LYASE INHIBITORS.
EP0318490B1 (en) 14,17-g(b)-ethano-14-g(b)-estratrienes, process for their manufacture and pharmaceutical preparations containing these
US3576828A (en) Delta**4,9,11-trienes of the 19-nor-androstene series and process for their manufacture
DE4132182A1 (en) 11 (BETA) SUBSTITUTED 14, 17-ETHANOESTRATRIA, METHOD FOR PRODUCING THESE COMPOUNDS, AND THEIR USE FOR THE PRODUCTION OF MEDICINAL PRODUCTS
GB1147802A (en) Improvements in or relating to novel steroids and the manufacture thereof
US3301756A (en) 19-nor steroids oxygenated in the 11-position, process of preparation and utilization
Dorfman et al. Steroid anti-estrogens
US3138527A (en) Topical anti-inflammatory process
US4081538A (en) Aldosterone antagonists
US3272708A (en) 20-aminomethyl-21-amino-pregnanes and therapeutic compositions thereof
US3984476A (en) D-homo-19-norsteroids
US3167547A (en) 17-tetrahydropyranyl ethers of 19-nor, 3-keto androstanes
EP0034114B1 (en) 3-desoxy-delta-15 steroids, process for their preparation and pharmaceutical compositions containing them
US3842074A (en) 18-methylene-steroids of the pregnane series
US3453296A (en) Delta**1-7alpha-methyl-androstenes
US3691212A (en) 17alpha-(1&#39;,3&#39;-alkadiynyl)-17beta-acyloxy(17beta-aroyloxy) steroids
IL41506A (en) 15alpha,16alpha-methylene-delta4-oestren-17beta-ols
DE1952461C3 (en) 17 alpha-acetoxy-7 alpha-alkylthioprogesterone Process for their preparation and medicinal products containing them
US3126376A (en) Fluorinated anbrostenes and inter-
EP1242445B1 (en) 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds
US3789087A (en) 4,6-dichlor- {66 {11 {11 {11 -steroids and method of making and using the same